Hello, I am Park Yeong min, the CEO of the Korea Drug Development Fund (Korea Drug Development Fund).

Korea’s pharmaceutical and biotechnology industries have focused on the development of new drugs, building world-class capabilities and brining the country a step closer to becoming a powerhouse in the sectors. Due a sluggish global economy and the fallout from the COVID-19 pandemic, however, the industries are now experiencing an extremely challenging time. This difficult situation has made the role of KDDF more important than ever as it offers research institutions substantial help in identifying non-essential budget elements and maximizing their results in the most cost-effective manner. We should set our priorities right and concentrate our resources on core sectors, and in particular, for the advancement of the 12 national strategic technologies selected by the government. We also need to maximize the value of new drugs by removing bottlenecks in the development process and making greater investment in innovative drug pipelines. For these overarching objectives, KDDF will drive its energy toward the following four fronts.

Scientific Discipline
Strive to develop new drugs based on the most appropriate research methodologies

Cooperation and Openness
Cooperate actively with a variety of experts and institutions at home and abroad to propagate research results worldwide and promote knowledge sharing, in order to strengthen the country’s drug development capabilities

Ethical Responsibility
Adhere to globally recognized ethical principles in the research and development process

Social Contribution
Leverage new drug development as a tool to improve public health and create economic and industrial value, equipping the nation to proactively respond to changes in an increasingly competitive world

KDDF is committed to achieving the greatest outcome under the principles of trust and impartiality. Your continued interest and support would be a great source of motivation for us.

Park Yeong min
CEO of Korea Drug Development Fund